Latest Advocacy Group Content

Latest Content

What My Grandpa Never Had to Know About My Cancer

November 27th 2020, 5:00pm

By Marissa Holzer

Article

My grandpa always lived life to the fullest, until the day he couldn't. And while he did, he didn't have to know about my cancer diagnosis.

Friday Frontline: NCI Research Project Identifies Genomic Mutations That Helped “Exceptional Responders”, a 15-Year-Old Cancer Survivor Dies of COVID-19, And More

November 27th 2020, 4:00pm

By Conor Killmurray

Article

Form the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

How Theranostics Could Impact the Future of Prostate Cancer Treatment

November 27th 2020, 2:00pm

By Jessica Skarzynski

Article

The field of theranostics is growing, and its impact could change the future of prostate cancer treatment. CURE® discusses this potential with a theranostics expert.

4 Tips for Adjusting to Holidays Amid COVID-19 While in Treatment for Cancer

November 26th 2020, 5:00pm

By Barbara Tako

Article

Adjusting to the unique holiday season amid the COVID-19 pandemic, all while going through treatment for cancer requires extra kindness and willingness to change some habits. Here are 4 tips to do just that.

Smiling Through Cancer Treatment Amid the COVID-19 Pandemic

November 26th 2020, 4:00pm

By Ryan McDonald

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic. We talked about her cancer journey, what it was like to receive treatment during the pandemic, and more.

CURE’s Clinical Trial Corner: November 2020

November 26th 2020, 2:00pm

By Ryan McDonald

Article

Here is a list of some recent trials that launched within the cancer space in November.

FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma

November 25th 2020, 11:13pm

By Darlene Dobkowski, MA

Article

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

First-Line Treatment with Additional Combination Therapy After Resection May Improve Survival for Pancreatic Cancer

November 25th 2020, 10:00pm

By Darlene Dobkowski, MA

Article

This survival benefit was particularly observed in patients with node-positive disease, or cancer that spread to the lymph nodes according to pathology.

Theranostics 101: Combining Therapeutics and Diagnostics to Treat Prostate Cancer

November 25th 2020, 7:00pm

By Jessica Skarzynski

Video

Theranostics, or the method of using one radioactive drug to diagnose a malignancy and a second radioactive drug to treat that cancer, is gaining in popularity in the treatment of prostate cancer.

Mammograms Feel Very Different to A Cancer Caregiver

November 25th 2020, 5:00pm

By Debbie Legault

Article

In the wake of a cancer journey as a caregiver, mammogram appointments have a new meaning, and new emotions, associated with them than before.

x